162 related articles for article (PubMed ID: 37545697)
1. Interference of anti-nuclear antibodies on determination of anti-neutrophil cytoplasmic antibodies in patients suspected of vasculitis: a case series.
Mahto M; Rai N; Das PR; Karmakar S; Bhushan D
Biochem Med (Zagreb); 2023 Oct; 33(3):031001. PubMed ID: 37545697
[TBL] [Abstract][Full Text] [Related]
2. Detection rate and antigenic specificities of antineutrophil cytoplasmic antibodies in chinese patients with clinically suspected vasculitis.
Xin G; Zhao MH; Wang HY
Clin Diagn Lab Immunol; 2004 May; 11(3):559-62. PubMed ID: 15138182
[TBL] [Abstract][Full Text] [Related]
3. Indirect immunofluorescence (IIF) of normal washed peripheral blood cells to demonstrate antineutrophil cytoplasmic antibodies (ANCA).
Paspaliaris B; Pamio M; Savige J
J Clin Pathol; 2000 Oct; 53(10):774-7. PubMed ID: 11064672
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization.
Hagen EC; Daha MR; Hermans J; Andrassy K; Csernok E; Gaskin G; Lesavre P; Lüdemann J; Rasmussen N; Sinico RA; Wiik A; van der Woude FJ
Kidney Int; 1998 Mar; 53(3):743-53. PubMed ID: 9507222
[TBL] [Abstract][Full Text] [Related]
5. Testing and reporting antineutrophil cytoplasmic antibodies (ANCA) in treated vasculitis and non-vasculitic disease.
Savige J; Trevisin M; Pollock W
J Immunol Methods; 2018 Jul; 458():1-7. PubMed ID: 29486145
[TBL] [Abstract][Full Text] [Related]
6. The value of anti-neutrophil cytoplasmic antibodies (ANCA) testing for the diagnosis of ANCA-associated vasculitis, a systematic review and meta-analysis.
Guchelaar NAD; Waling MM; Adhin AA; van Daele PLA; Schreurs MWJ; Rombach SM
Autoimmun Rev; 2021 Jan; 20(1):102716. PubMed ID: 33197574
[TBL] [Abstract][Full Text] [Related]
7. Audit of the clinical usefulness of a rapid qualitative ELISA screen for antimyeloperoxidase and antiproteinase 3 antibodies in the assessment of patients with suspected vasculitis.
Aslam A; Newman TL; Misbah SA
J Clin Pathol; 2003 Oct; 56(10):775-7. PubMed ID: 14514783
[TBL] [Abstract][Full Text] [Related]
8. Determination of anti-neutrophil cytoplasmic antibodies in small vessel vasculitis: Comparative analysis of different strategies.
Vermeersch P; Vervaeke S; Blockmans D; van Hoovels L; Mariën G; Vanmaele H; Bossuyt X
Clin Chim Acta; 2008 Nov; 397(1-2):77-81. PubMed ID: 18708041
[TBL] [Abstract][Full Text] [Related]
9. A study of anti-neutrophil cytoplasm antibodies in systemic vasculitis and other related disorders.
Pradhan VD; Badakere SS; Iyer YS; Kumar R; Almeida AF
J Postgrad Med; 2003; 49(1):5-9; discussion 9-10. PubMed ID: 12865563
[TBL] [Abstract][Full Text] [Related]
10. Use of immunofluorescence and confocal laser scanning microscopy in identifying rare cases of anti-neutrophil cytoplasmic antibodies (ANCA) showing dual specificities to myeloperoxidase and proteinase3.
Badakere SS; Pradhan VD; Almeida AF; Pawar AR
J Fluoresc; 2004 Jul; 14(4):459-63. PubMed ID: 15617388
[TBL] [Abstract][Full Text] [Related]
11. Detection of antineutrophil cytoplasmic antibodies (ANCAs): a multicentre European Vasculitis Study Group (EUVAS) evaluation of the value of indirect immunofluorescence (IIF) versus antigen-specific immunoassays.
Damoiseaux J; Csernok E; Rasmussen N; Moosig F; van Paassen P; Baslund B; Vermeersch P; Blockmans D; Cohen Tervaert JW; Bossuyt X
Ann Rheum Dis; 2017 Apr; 76(4):647-653. PubMed ID: 27481830
[TBL] [Abstract][Full Text] [Related]
12. International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA).
Savige J; Gillis D; Benson E; Davies D; Esnault V; Falk RJ; Hagen EC; Jayne D; Jennette JC; Paspaliaris B; Pollock W; Pusey C; Savage CO; Silvestrini R; van der Woude F; Wieslander J; Wiik A
Am J Clin Pathol; 1999 Apr; 111(4):507-13. PubMed ID: 10191771
[TBL] [Abstract][Full Text] [Related]
13. A review of immunofluorescent patterns associated with antineutrophil cytoplasmic antibodies (ANCA) and their differentiation from other antibodies.
Savige JA; Paspaliaris B; Silvestrini R; Davies D; Nikoloutsopoulos T; Sturgess A; Neil J; Pollock W; Dunster K; Hendle M
J Clin Pathol; 1998 Aug; 51(8):568-75. PubMed ID: 9828813
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of positive anti-neutrophil cytoplasmic antibodies without evidence of anti-neutrophil cytoplasmic antibodies-associated vasculitis.
Bornstein G; Ben-Zvi I; Furie N; Grossman C
Int J Rheum Dis; 2019 May; 22(5):940-945. PubMed ID: 30729688
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous automated screening and confirmatory testing for vasculitis-specific ANCA.
Sowa M; Grossmann K; Knütter I; Hiemann R; Röber N; Anderer U; Csernok E; Bogdanos DP; Borghi MO; Meroni PL; Schierack P; Reinhold D; Conrad K; Roggenbuck D
PLoS One; 2014; 9(9):e107743. PubMed ID: 25225805
[TBL] [Abstract][Full Text] [Related]
16. Clinical spectrum associated with ANCA of defined antigen specificities in 98 selected patients.
Geffriaud-Ricouard C; Noël LH; Chauveau D; Houhou S; Grünfeld JP; Lesavre P
Clin Nephrol; 1993 Mar; 39(3):125-36. PubMed ID: 7681736
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of classical and atypical antineutrophil cytoplasmic antibody (ANCA) immunofluorescence patterns.
Wong RC; Silvestrini RA; Savige JA; Fulcher DA; Benson EM
J Clin Pathol; 1999 Feb; 52(2):124-8. PubMed ID: 10396240
[TBL] [Abstract][Full Text] [Related]
18. What do antineutrophil cytoplasmic antibodies (ANCA) tell us?
Savige J; Pollock W; Trevisin M
Best Pract Res Clin Rheumatol; 2005 Apr; 19(2):263-76. PubMed ID: 15857795
[TBL] [Abstract][Full Text] [Related]
19. Contribution of immunofluorescence to the identification and characterization of anti-neutrophil cytoplasmic autoantibodies. The role of different fixatives.
Radice A; Vecchi M; Bianchi MB; Sinico RA
Clin Exp Rheumatol; 2000; 18(6):707-12. PubMed ID: 11138332
[TBL] [Abstract][Full Text] [Related]
20. [Rapid-detection GBM-ANCA ELISA. An emergency tool for the early diagnosis of type I and II rapidly progressive glomerulonephritis].
Arranz O; Ara J; Rodríguez R; Poveda R; Serra A; Solé-Amigó J; Fort J; Mirapeix E; Darnell A
Nefrologia; 2001; 21(4):349-54. PubMed ID: 11816510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
